chenodeoxycholic acid has been researched along with rifaximin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bifulco, G; Chini, MG; D'Amore, C; D'Auria, MV; Debitus, C; Fiorucci, S; Renga, B; Sepe, V; Ummarino, R; Zampella, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for chenodeoxycholic acid and rifaximin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for chenodeoxycholic acid and rifaximin
| Article | Year |
|---|---|
Conicasterol E, a small heterodimer partner sparing farnesoid X receptor modulator endowed with a pregnane X receptor agonistic activity, from the marine sponge Theonella swinhoei.
Topics: Animals; Aquatic Organisms; Bile Acids and Salts; Binding Sites; Cell Line, Tumor; Chenodeoxycholic Acid; Cholesterol; Humans; Models, Molecular; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Rifamycins; Rifaximin; Theonella; Transcriptional Activation | 2012 |